Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
复制标题
DOI:
10.1186/s12929-017-0377-1
复制
发表时间:
2017-09-09
影响因子:
11
通讯作者:
Greig NH
中科院分区:
文献类型:
--
作者:
Hoffer BJ;Pick CG;Hoffer ME;Becker RE;Chiang YH;Greig NH
Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality of both young adults of less than 45 years of age and the elderly, and contributes to about 30% of all injury deaths in the United States of America. Whereas there has been a significant improvement in our understanding of the mechanism that underpin the primary and secondary stages of damage associated with a TBI incident, to date however, this knowledge has not translated into the development of effective new pharmacological TBI treatment strategies. Prior experimental and clinical studies of drugs working via a single mechanism only may have failed to address the full range of pathologies that lead to the neuronal loss and cognitive impairment evident in TBI and other disorders. The present review focuses on two drugs with the potential to benefit multiple pathways considered important in TBI. Notably, both agents have already been developed into human studies for other conditions, and thus have the potential to be rapidly repositioned as TBI therapies. The first is N-acetyl cysteine (NAC) that is currently used in over the counter medications for its anti-inflammatory properties. The second is (−)-phenserine ((−)-Phen) that was originally developed as an experimental Alzheimer’s disease (AD) drug. We briefly review background information about TBI and subsequently review literature suggesting that NAC and (−)-Phen may be useful therapeutic approaches for TBI, for which there are no currently approved drugs.
登录
查看更多内容
影响因子:
82.9
作者:
Eriksson, PS;Perfilieva, E;Gage, FH
通讯作者:
Gage, FH
影响因子:
4.3
作者:
Chang EH;Adorjan I;Mundim MV;Sun B;Dizon ML;Szele FG
通讯作者:
Szele FG
影响因子:
3.7
作者:
Eakin K;Baratz-Goldstein R;Pick CG;Zindel O;Balaban CD;Hoffer ME;Lockwood M;Miller J;Hoffer BJ
通讯作者:
Hoffer BJ
影响因子:
4.6
作者:
Chen, Gang;Shi, Jixin;Hu, Zhigang;Hang, Chunhua
通讯作者:
Hang, Chunhua
影响因子:
17.1
作者:
Goldstein LE;Fisher AM;Tagge CA;Zhang XL;Velisek L;Sullivan JA;Upreti C;Kracht JM;Ericsson M;Wojnarowicz MW;Goletiani CJ;Maglakelidze GM;Casey N;Moncaster JA;Minaeva O;Moir RD;Nowinski CJ;Stern RA;Cantu RC;Geiling J;Blusztajn JK;Wolozin BL;Ikezu T;Stein TD;Budson AE;Kowall NW;Chargin D;Sharon A;Saman S;Hall GF;Moss WC;Cleveland RO;Tanzi RE;Stanton PK;McKee AC
通讯作者:
McKee AC